Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

April 2009

22 Apr Clopidogrel for the treatment of adult patients following acute coronary syndrome

Posted at 13:46h in Drug Assessments 2 Comments
Share

Introduction: this is an update of the November 2004 Therapeutics Initiative systematic review report. Research questions: “Are there any clinical advantages to the use of clopidogrel, in combination with ASA, for twelve months as compared to...

Read More
Link icon

06 Apr Statin Adherence and risk of accidents: a cautionary tale

Posted at 23:29h in PharmacoEpidemiology 0 Comments
Share

Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA Link to publication...

Read More

adverse effects adverse events antibacterial agents antidepressive agents biosimilars blood pressure chronic obstructive pulmonary disease chronic pain COPD covid-19 dental infections deprescribing Deprescriptions Diabetes Diabetes Mellitus Drug-Related Side Effects and Adverse Reactions drug safety elderly empagliflozin exercise gabapentin Glycemic Control guidelines hypertension hypoglycemic agents inappropriate prescribing Mass Screening methods opioid analgesics opioids overdiagnosis oxycodone pain pharmacoepidemiology polypharmacy portrait pregabalin prescribing proton pump inhibitors Ritonavir safety SGLT2 smoking cessation Sodium-Glucose Transporter 2 Inhibitors tramadol

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2022 Therapeutics Initiative | Terms & Policies